跳至主要内容
临床试验/NL-OMON23721
NL-OMON23721尚未招募不适用

Subthalamic nucleus DBS versus globus pallidus DBS for advanced Parkinson’s disease.

Academic Medical Center - University of Amsterdam0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
128

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Idiopathic Parkinson's disease and—despite optimal pharmacological treatment—at least one of the following symptoms: severe response fluctuations, dyskinesias, painful dystonias, or bradykinesia.

排除标准

  • 1. Age below 18 years;
  • 2. Previous functional stereotactic neurosurgery;
  • 3. Hoehn and Yahr stage 5 at the best moment during the day;
  • 4. A Mattis dementia rating scale score of less than 120;
  • 5. Psychosis, and contraindications for stereotactic neurosurgery such as a physical disorder making surgery hazardous (severe hypertension, blood coagulation disorder, severe dysphagia, or dysphasia).

研究者

相似试验